Imaging Approach for Cervical Lymph Node Metastases from Unknown Primary Tumor

医学 原发性肿瘤 淋巴结 转移 放射科 颈淋巴结 癌症 头颈部癌 头颈部鳞状细胞癌 病理 钙化 放射治疗 内科学
作者
Sota Masuoka,Takashi Hiyama,Hirofumi Kuno,Sekiya Koike,Shingo Sakashita,Tatsushi Kobayashi
出处
期刊:Radiographics [Radiological Society of North America]
卷期号:43 (3)
标识
DOI:10.1148/rg.220071
摘要

Neck swelling due to lymph node (LN) metastasis is one of the initial symptoms of head and neck cancer, and in some cases, the primary tumor is not clinically evident. The purpose of imaging for LN metastasis from an unknown primary site is to identify the primary tumor or detect its absence, which leads to the correct diagnosis and optimal treatment. The authors discuss diagnostic imaging approaches for identifying the primary tumor in cases of unknown primary cervical LN metastases. The distribution and characteristics of LN metastases may help locate the primary site. Unknown primary LN metastasis often occurs at nodal levels II and III, and in recent reports, these were mostly related to human papillomavirus (HPV)–positive squamous cell carcinoma of the oropharynx. Another characteristic imaging finding suggestive of metastasis from HPV-associated oropharyngeal cancer is a cystic change in LN metastases. Other characteristic imaging findings such as calcification may help predict the histologic type and locate the primary site. In cases of LN metastases at nodal levels IV and VB, a primary lesion located outside the head and neck region must also be considered. One clue for detecting the primary lesion at imaging is the disruption of anatomic structures, which can help in identifying small mucosal lesions or submucosal tumors at each subsite. Additionally, fluorine 18 fluorodeoxyglucose PET/CT may help identify a primary tumor. These imaging approaches for identifying primary tumors enable prompt identification of the primary site and assist clinicians in making the correct diagnosis. © RSNA, 2023 Quiz questions for this article are available through the Online Learning Center.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
3秒前
4秒前
4秒前
省略号完成签到,获得积分10
5秒前
丘比特应助学术学习渣子采纳,获得10
7秒前
8秒前
GGgg完成签到,获得积分10
8秒前
沉默是金发布了新的文献求助10
9秒前
9秒前
英姑应助傻子与白痴采纳,获得10
9秒前
今后应助aara采纳,获得10
9秒前
草莓星完成签到,获得积分10
10秒前
WWTWM发布了新的文献求助10
10秒前
马六甲完成签到,获得积分10
10秒前
逸雨涵梦完成签到 ,获得积分10
10秒前
瑞哥哥完成签到 ,获得积分10
11秒前
子车兰完成签到,获得积分10
11秒前
iNk应助Clare采纳,获得10
12秒前
12秒前
OIIII发布了新的文献求助10
13秒前
cca完成签到,获得积分20
13秒前
13秒前
充电宝应助大胆的迎松采纳,获得10
13秒前
13秒前
空海发布了新的文献求助10
14秒前
14秒前
14秒前
15秒前
16秒前
Rain发布了新的文献求助30
16秒前
17秒前
17秒前
宋万里发布了新的文献求助10
18秒前
19秒前
19秒前
月与海完成签到,获得积分10
19秒前
OIIII完成签到,获得积分10
19秒前
沧笙踏歌发布了新的文献求助30
20秒前
20秒前
嘟嘟发布了新的文献求助10
20秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Prompt Engineering for Clinicians: Harnessing AI in Everyday Medical Practice 600
Electrode Potentials 550
REAL-WORLD EFFICACY AND GENOMIC LANDSCAPE OF POLATUZUMA VEDOTIN-BASED FIRST-LINE THERAPY IN DIFFUSE LARGE B-CELL LYMPHOMA: A FOCUS ON TP53 MUTATIONS AND TREATMENT RESPONSE 500
Handbook of Luminescence Dating 500
Safety Pharmacology 500
《KNN基无铅压电陶瓷电学性能优化与物理机理研究》 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 计算机科学 化学工程 生物化学 物理 内科学 复合材料 催化作用 光电子学 物理化学 电极 细胞生物学 基因 遗传学
热门帖子
关注 科研通微信公众号,转发送积分 6960518
求助须知:如何正确求助?哪些是违规求助? 8643289
关于积分的说明 18329842
捐赠科研通 6409080
什么是DOI,文献DOI怎么找? 3085609
关于科研通互助平台的介绍 2133775
邀请新用户注册赠送积分活动 2062172